New Cancer Drug Reboots Stalled Immunotherapies

River D'Almeida, Ph.D
The Reading Frame
Published in
2 min readNov 2, 2020

--

In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumor cells. The hope is that these types of treatments will be more effective at permanently eliminating cancer cells and have fewer side effects due to their more targeted nature. However, clinical testing of immunotherapeutics has revealed that certain types of malignancies are resistant to…

--

--

River D'Almeida, Ph.D
The Reading Frame

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.